Biocatalyst Market Analysis

Regarding the source, the biocatalyst market share is classified into Plants, Animals, and Microorganisms. The microorganisms segment is set to expand at over 6% CAGR between 2023 and 2032, attributed to the easy, consistent, and cost-effective production of biocatalysts through microorganisms. Microbial-catalyzed biotransformations retain substantial potential in generating a variety of structurally diversified organic compounds, specifically natural products with intricate structures such as flavonoids, triterpenoids, steroids, sesquiterpenoids, and steroidal saponins. Consistent R&D efforts toward obtaining biologically active molecules with myriad structural features will drive segment share.
 

Biocatalysts find extensive applications in food and beverages, cleaning agents, biofuel production, agriculture and feed, biopharmaceuticals, and others. The industry revenue from the biopharmaceuticals segment is anticipated to grow at 7% CAGR from 2023 to 2032, owing to the growing usage of biocatalysts resulting in high-quality biopharmaceutical ingredients like proteins, nucleic acids, etc. Additionally, the increasing R&D investments on several drug development projects will further aid segment size.
 

Geographically, the Europe biocatalyst market is expected to garner USD 280 million in revenues by 2032. Europe is one of the leading pharmaceutical manufacturers globally. In 2020, the region invested an estimated € 39,000 million in R&D, as per the European Federation of Pharmaceutical Industries and Associations. High research and development activities due to advanced technological innovation in the biocatalyst domain is another crucial factor positively impacting the market trends.